Investing
The deal values 23andMe at approximately $3.5 billion through the combination of stock and cash financing.
The B2B platform, billed as the “plug and play” option for insurance companies, will use the funding to expand operations in new markets and add languages.
The company plans to use the money to grow in the life science and AI research space.
The new funds will be put towards expanding into Indonesia, Philippines, Malaysia and India.
Also HealthTensor scores $5 million in seed funding and Cutback Coach rakes in $3.1 million for its platform designed to help users cut back on alcohol.
Reproductive health firm Suzhou Basecare Medical Co.
The Wild Card open innovation programme has selected two innovator teams from Spain and Germany.
The round was led by Todd Cozzens and had participation from existing investors Khosla Ventures, Founders Fund, Green Innovations, Vesalius Biocapital and Faber.
Roundup: DNA Script signs contract with French Department of Defence, Octopus Ventures announces ne…
Also, Raccoon.World raises further €660K for its physiotherapy telemedicine platform.
This latest funding announcement comes off the heels of a massive funding year for Lyra Health.